Transcriptome and miRNA network analysis of familial hypercholesterolemia

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Disease

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder causing high low-density lipoprotein (LDL) cholesterol levels.
• Elevated LDL cholesterol accelerates atherosclerosis and increases the risk of premature coronary heart disease.

Purpose of the Study:

• To identify gene expression profiles distinguishing FH patients from healthy controls.
• To explore transcriptional interactions in FH by analyzing transcription factors (TFs), microRNAs (miRNAs), and pathways.
• To construct a regulatory network for identifying novel FH-associated genes.

Main Methods:

• DNA microarray analysis to identify differential gene expression.
• Bioinformatic analysis of publicly available microarray and regulation data.
• Construction of a regulatory network to map gene interactions in FH.

Main Results:

• Specificity protein 1 (SP1), STAT1, and SPI1 were identified as central players in the FH regulatory network.
• Upstream transcription factor 2 (USF2) and Wiskott-Aldrich syndrome (WAS) gene were newly associated with FH.
• Transcriptional network analysis revealed potential novel therapeutic targets for FH.

Conclusions:

• Gene expression profiling and network analysis are effective for understanding FH pathogenesis.
• Identification of key TFs and genes provides insights into FH regulatory mechanisms.
• Novel targets like USF2 and WAS may offer new therapeutic avenues for FH.